Ignite Creation Date:
2025-12-24 @ 7:30 PM
Ignite Modification Date:
2026-03-01 @ 11:20 PM
Study NCT ID:
NCT05327803
Status:
TERMINATED
Last Update Posted:
2025-05-08
First Post:
2022-03-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Sponsor:
AN2 Therapeutics, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EBO-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None